Corbus Pharmaceuticals
CRBP
#8921
Rank
NZ$0.23 B
Marketcap
NZ$13.48
Share price
-1.81%
Change (1 day)
-21.03%
Change (1 year)

Market capitalization of Corbus Pharmaceuticals (CRBP)

Market cap: NZ$0.23 Billion

As of February 2026 Corbus Pharmaceuticals has a market cap of NZ$0.23 Billion. This makes Corbus Pharmaceuticals the world's 8921th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Corbus Pharmaceuticals from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$0.23 B-6.25%
2025NZ$0.25 B-8.31%
2024NZ$0.27 B551.71%
2023NZ$42.25 M93.77%
2022NZ$21.8 M-80.68%
2021NZ$0.11 B-22.46%
2020NZ$0.14 B-72.23%
2019NZ$0.52 B5.2%
2018NZ$0.49 B-10.28%
2017NZ$0.55 B2.48%
2016NZ$0.54 B497.94%
2015NZ$90.65 M-8.41%
2014NZ$98.98 M

End of Day market cap according to different sources

On Feb 2nd, 2026 the market cap of Corbus Pharmaceuticals was reported to be:

NZ$0.24 Billion
by Nasdaq info icon info icon
NZ$0.24 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Viking Therapeutics
VKTX
NZ$5.39 B 2,178.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Vanda Pharmaceuticals
VNDA
NZ$0.78 B 232.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Epizyme
EPZM
NZ$0.41 B 73.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Advaxis
ADXS.defunct
NZ$2.11 M-99.10%๐Ÿ‡บ๐Ÿ‡ธ USA